Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 14, 1147 - 1148 (2008)
doi:10.1038/nm1108-1147
Healing hemangiomas
Lena Claesson-Welsh1
- Lena Claesson-Welsh is in the Department of Genetics and Pathology, Uppsala University, Dag Hammarskjölds väg 20, 751 85 Uppsala, Sweden.
e-mail: Lena.Welsh@genpat.uu.se
Abstract
Defective signaling of vascular endothelial growth factor seems to underlie the development of hemangiomas, disfiguring tumors arising early in life (pages 1236–1246).
Hemangiomas are common, benign tumors that appear in particular locations, commonly in the face and neck region1. As they form, endothelial cells—the cells that form the inner lining of blood vessels—lose their ability to organize in lumenized structures and instead form a proliferating mass of cells.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangiomaNature Medicine Article (01 Nov 2008)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine Article (01 May 2001)
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1Nature Medicine Article (01 Aug 2002)
